All In Biotech

Free tool

FAERS Monitor: Adempas

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 204819 or its brand name (Adempas, Riociguat). Reports on generic versions are filed under their own applications.

Reports

32,879

Serious

25,172

77% of reports

Hospitalization

15,491

Death reported

7,129

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea5,794
  • death5,421
  • headache4,575
  • nausea3,819
  • dizziness3,589
  • diarrhoea3,574
  • hypotension3,452
  • fatigue3,021
  • hospitalisation2,326
  • vomiting2,147
  • cough1,827
  • oedema peripheral1,802
  • pneumonia1,781
  • fluid retention1,769
  • malaise1,689

Reports by year received

View as table
YearReports
20114
201210
201350
2014837
20151,491
20162,606
20172,909
20183,297
20193,075
20203,101
20212,953
20222,850
20232,902
20243,038
20252,363
20261,393

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,280 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
fluid retentionSignal1,76923.022.036,024
hypotensionSignal3,45211.210.831,753
hospitalisationSignal2,3269.89.418,266
oedema peripheralSignal1,8029.69.213,720
dyspnoeaSignal5,7946.66.528,024
headacheSignal4,5754.74.613,609
dizzinessSignal3,5894.64.510,381
coughSignal1,8274.24.04,462
deathSignal5,4214.03.912,869
diarrhoeaSignal3,5743.63.46,734
pneumoniaSignal1,7813.53.43,264
nauseaSignal3,8193.13.05,605
vomitingSignal2,1472.92.82,777
fatigueSignal3,0212.52.42,779
malaiseSignal1,6892.52.41,501

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.